Clin2
NCT07260942Possibly a fitRecruiting

Study of ferroptosis in lupus

Systemic Lupus Erythematosus

Treatments studied

Part of Immune system & allergy, Skin clinical trials.

This study looks at whether a type of cell death called ferroptosis plays a role in lupus. Participants with lupus or with rheumatoid arthritis or inflammatory bowel disease will be compared to understand more about how lupus works.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older.
  • You have been diagnosed with systemic lupus erythematosus (lupus), OR you have been diagnosed with rheumatoid arthritis or an inflammatory bowel disease (like Crohn's or ulcerative colitis) — the study includes both groups.
  • You are willing to take part and sign a consent form.
  • You are not pregnant or breastfeeding.
  • You are not under any legal protection or unable to consent on your own.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05698173Recruiting
Study of lupus and accelerated aging

This study looks at how lupus relates to “accelerated aging” and may help researchers better understand disease effects over time. You might be able to join if you have systemic lupus and are able to consent and participate.

Bordeaux
NCT05859191Recruiting
Study of immune cell markers in people with lupus

This study looks at how certain immune cells (natural killer T cells) behave in people with systemic lupus, by measuring specific immune receptor markers in blood. It may help researchers better understand lupus and how it can connect with other conditions like antiphospholipid syndrome or Sjögren’s.

Tours
NCT07323173Recruiting· Phase 1
Safety study of LBL-047 in healthy adults and lupus patients

This study tests a new drug called LBL-047 in healthy people and in people with mild to moderate lupus. It helps check if the drug is safe and how the body processes it. Participating may help find better treatments for lupus.

Bengbu, Anhui
NCT00001372Recruiting
Understanding Lupus: Research Study at NIH

This research study aims to better understand systemic lupus erythematosus (SLE), an autoimmune disease where the body's immune system attacks its own tissues. Researchers will evaluate patients with lupus, study genetic factors, and perform optional imaging tests to learn how the disease affects blood vessels and the heart.

Bethesda, Maryland
NCT07102030Recruiting
Understanding lupus subgroups to improve treatment

This study is trying to better understand lupus (SLE) by looking at different types of the disease. It may help doctors find more personalized treatments in the future.

Stockholm
NCT05924074Recruiting
Study of ferroptosis therapy in blood disorders with SF3B1 mutation

This study looks at ferroptosis (a type of cell stress that can affect blood-forming cells) in people with certain blood disorders linked to an SF3B1 gene change. It may help researchers understand whether targeting this pathway could improve outcomes.

Pessac

Hear when a new Systemic Lupus Erythematosus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.